ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, today announced that the Company was prominently featured by the newspaper “Investor’s Business Daily” in an in-depth article highlighting top investment opportunities in the embryonic stem cell industry.
